DHDedy Hermansyah

Dedy Hermansyah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dedy Hermansyah has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chemotherapy-Induced Upregulation of X-Linked Inhibitor of Apoptosis Protein Is Associated with Survival After Chemotherapy in Triple-Negative Breast Cancer

    by Muhammad Al Anas, Suyatno Suyatno, Endi Taris Pasaribu, Dedy Hermansyah

    Background and Objectives: Triple-negative breast cancer remains difficult to treat because endocrine and HER2-directed therapies are not applicable, leaving cytotoxic chemotherapy as an important systemic treatment. We examined whether chemotherapy exposure was accompanied by XIAP upregulation in an MDA-MB-231 model and whether XIAP expression was associated with the surviving cell fraction.Methods: MDA-MB-231 cells obtained from ATCC were exposed to graded concentrations of paclitaxel and doxorubicin. Cytotoxicity was assessed by MTT assay. A combined paclitaxel–doxorubicin condition was evaluated for surviving cell fraction. XIAP messenger RNA was quantified by reverse-transcription real-time polymerase chain reaction using GAPDH for normalization and the 2−ΔΔCt method. An exploratory Eta coefficient was calculated to describe the association between XIAP expression and chemotherapy survival.Results: Paclitaxel and doxorubicin produced concentration-dependent inhibition. Estimated IC50 values were 0.423 µg/mL and 1.74 µg/mL, respectively. Combined treatment yielded 580,000 viable cells versus 2,000,000 in the untreated control, corresponding to a surviving fraction of 0.29. Relative XIAP expression in the treated sample was 178.53-fold that of the untreated control. The exploratory Eta coefficient was 0.748.Conclusions: Chemotherapy exposure was accompanied by a marked increase in XIAP transcript abundance in the surviving cell population. The finding supports XIAP as a biologically plausible marker of chemotherapy tolerance, but causality cannot be established from the present design. Independent biological replicates, protein-level validation, apoptosis assays, and XIAP perturbation are required before therapeutic conclusions can be drawn.

  • Open Access

    Integrated Transcriptomic Analysis Identifies Overlapping Gene Networks Between Breast Cancer Stem Cells and Paclitaxel-Primed Mesenchymal Stem Cell-Activated T Cells as Potential Immunotherapeutic Targets

    by Yan Wisnu Prajoko, Dedy Hermansyah, Tri Widiandani, Nur Dina Amalina

    Background: Breast cancer stem cells (BCSCs) are responsible for chemotherapy resistance, metastasis, and tumor recurrence. Paclitaxel-primed mesenchymal stem cells (MSCs) can activate T cells, offering a novel immunotherapeutic approach. However, the molecular mechanisms underlying BCSC-immune interactions remain poorly understood. Objective: To identify overlapping gene networks between BCSCs, paclitaxel-treated cells, activated T cells, and paclitaxel-primed MSCs, and to validate their functional relevance in targeting BCSCs. Methods: Comparative transcriptomic analysis was performed using data from TCGA to identify genes co-expressed across BCSCs, paclitaxel-treated cells, activated T cells, and MSCs. Protein-protein interaction network analysis, Gene Ontology (GO) enrichment, and KEGG pathway mapping were conducted using STRING-DB, DAVID, and cBioPortal. Mutation analysis and survival correlations were assessed across 151 breast cancer samples. Experimental validation was performed using MTT viability assays and qRT-PCR in metastatic breast cancer cells treated with paclitaxel, activated T cell-conditioned medium, and MSC-derived factors. Results: We identified 158 genes co-expressed across all four conditions, forming a highly interconnected PPI network (136 nodes, 524 edges). Network centrality analysis revealed TP53, AKT1, and STAT3 as top hub genes. GO enrichment analysis demonstrated significant involvement in epithelial cell proliferation, stress responses, and transcriptional regulation. KEGG pathway analysis revealed enrichment in the PI3K-Akt signaling pathway, the PD-L1/PD-1 checkpoint pathway, and Th1/Th2 differentiation. TP53 was the most frequently mutated gene (77.5%), which correlated with a poor prognosis. Experimental validation demonstrated that combined paclitaxel and activated T cell treatment reduced BCSC viability by 75%, upregulated TP53 expression, and suppressed PIK3CA expression by 85%. Conclusion: This study reveals critical molecular networks connecting BCSCs and immune activation, identifying TP53, AKT1, and STAT3 as central therapeutic targets. Paclitaxel-primed MSC-activated T cells synergize with chemotherapy to suppress BCSC viability by modulating the TP53 and PIK3CA pathways, providing a mechanistic rationale for combinatorial immunotherapy in breast cancer.

  • Open Access

    Elevated neutrophil-to-lymphocyte ratio predicts poorer histopathological differentiation in colorectal cancer: a study from a Southeast Asian Tertiary Hospital

    by Edwin Saleh Siregar, Muhammad Al Anas, Dedy Hermansyah

    Aim of this study was to evaluate the correlation between pre-treatment NLR and histopathological differentiation in colorectal cancer, and to assess the diagnostic accuracy of NLR as a predictive biomarker. Methods A retrospective study was conducted at Adam Malik Haji Center General Hospital Medan, North Sumatera. Medical records of 45 colorectal cancer patients treated between January and December 2024 were reviewed. Pre-treatment NLR values were calculated from peripheral blood counts. Receiver Operating Characteristic (ROC) curve analysis was performed to determine diagnostic performance, and correlation analysis was used to assess the relationship between NLR and tumour grade. Results The mean NLR was 6.33±4.92. ROC analysis yielded an area under the curve (AUC) of 0.874, indicating excellent diagnostic ability. An NLR cutoff value of 6.25 provided a sensitivity of 87.5% and specificity of 72.5% for predicting poor histopathological differentiation. A moderate positive correlation (r=0.612; p<0.001) was found between higher NLR values and poorer differentiation. Conclusion Pre-treatment NLR correlated with histopathological grade and showed promise as a simple, non-invasive biomarker for assessing tumour aggressiveness in colorectal cancer.

  • Open Access

    Clinicopathological Characteristics of Young-Onset Breast Cancer Patients Stratified by Molecular Subtypes at H. Adam Malik Hospital

    by Raka Dutra Pratama, Dedy Hermansyah, Pimpin Utama Pohan

    Aim To examine and evaluate the clinicopathological characteristics of young-onset breast cancer across molecular subtypes in patients from Southeast Asia, with a specific focus on those treated at H. Adam Malik Hospital, Indonesia. Methods A descriptive observational study with a cross-sectional design was conducted on medical records of breast cancer patients aged <40 years treated at H. Adam Malik Hospital from January 2017 to December 2022. Data included demographic, clinical, histopathological, and immunohistochemical findings. Statistical analyses were performed descriptively. Results Among the 104 patients analyzed, 71 (69.2%) had T4 tumors, and 49 (47.1%) had NST-type tumors. Most cases lacked ER (72, 69.2%) and PR (71, 68.3%) expression. A total of 41 patients had poorly differentiated tumors, with the majority at stage IV. The HER-2 positive subtype was most common (39, 37.5%), followed by Luminal B (31, 29.8%) and TNBC (22, 21.2%). Conclusion Young-onset breast cancer at H. Adam Malik Hospital predominantly features advanced stages, aggressive histopathological grades, and a high prevalence of HER2-positive and Luminal B subtypes. These findings highlight the importance of early detection and personalized treatment approaches.


  • Open Access

    Correlation of Ki67 expression with estrogen receptor (ER) and progesterone receptor (PR) status in breast cancer

    by Dedy Hermansyah, Muhammad Al Anas, Kania Haura Chalisaturahmi, Mutiara Baitina, Karina Sugih Arto, Endi Taris Pasaribu

    Aim To determine whether Ki67 can be predicted through its correlation with the estrogen receptor (ER) and progesterone receptor (PR), to identify breast cancer subtypes and evaluate cell proliferation level and prognosis. Methods Patient clinical data were collected from medical records and pathology laboratory reports at Teaching Hospital, Faculty of Medicine, Universitas Sumatera Utara. Ki67 expression, as a proliferation marker, was measured and detected using immunohistochemistry (IHC). Ki67 data were categorized into two groups: 20% (high proliferation). Statistical analysis was conducted by calculating the frequency distribution and percentage of receptor status and using the χ2 test. Results The study revealed an inverse relationship between ER/PR status and Ki67 (<0.001). Low Ki67 levels were generally associated with positive ER/PR status, while high Ki67 levels showed increased frequency in ER/PR- negative cases. Conclusion: Ki67 expression can be determined based on the frequency of ER/PR status; however, these markers have distinct roles in the management of breast cancer patients.

  • Open Access

    Characteristics and Clinical Outcomes of Pediatric Thyroid Nodules: An In-depth Analysis from a Single-Center Study in Indonesia

    by Dedy Hermansyah, Muhammad Anas, Karina Sugih Arto, Melda Deliana, Aridamuriany Dwiputri Lubis

    Background: Pediatric thyroid carcinoma, the most common endocrine malignancy among children, displays a notably higher incidence rate of 16% compared to 5% in adults. This disease often presents as advanced illness in pediatric cases, yet there\'s a paucity of data on its clinical features in this demographic. Our study, a first in North Sumatera, Indonesia, aims to fill this gap by examining the clinical characteristics of pediatric thyroid carcinoma.Objective: This research endeavors to provide comprehensive data on the demographic and clinical profiles of pediatric patients with thyroid nodules treated at our institution. Methods: A retrospective descriptive study was conducted from 2018-2021, encompassing 35 pediatric patients (under 18 years) who underwent partial or total thyroidectomy for thyroid nodules. We reviewed and analyzed patient demographics and pathology results, presenting these as frequencies and percentages. Results: Of the patients, 85.7% (30 patients) were female, and 14.3% (5 patients) were male, with an average age of 15.66 years (ranging from 10 to over 16 years). The age distribution showed 60% (21 patients) between 16-18 years, 22.9% (8 patients) between 6-11 years, and 17.1% (6 patients) between 12-15 years. Diagnoses included Colloid Goitres (42.9%), Follicular Adenoma (22.9%), Papillary Thyroid Carcinoma (20%), Hashimoto Thyroiditis and Graves\' disease (5.7% each), and Follicular Neoplasm (2.9%). Conclusion: The study period witnessed a steady prevalence of pediatric thyroid nodules necessitating thyroidectomy. This underscores the critical need for early detection of thyroid nodules in children for malignancy screening. Timely diagnosis is paramount for favorable outcomes and prognoses in pediatric thyroid conditions.


  • Open Access

    Unveiling Paclitaxel-Induced Mesenchymal Stem Cells: orchestrating Nrf2 Modulation and Apoptosis in CD44+/CD24- Cancer Stem Cells

    by Dedy Hermansyah, Siti Syarifah, Adi Muradi Muhar, Agung Putra

    Background: Mesenchymal Stem Cells (MSCs) and Cancer Stem Cells (CSC) play pivotal roles in cancer progression and therapeutic responses. This study aimed to explored the effect of MSCs induced by paclitaxel on CSC expressing the CD44+/CD24- phenotype, focusing on Nrf2 modulation and apoptosis induction. Methods: MSCs were characterized for adherence, differentiation potential, and surface markers via standard culture, staining assays, and flow cytometry, respectively. CSCs isolated from MDA-MB-231 using MACS and were characterized based on morphology and CD44+/CD24- expression. Co-culture experiments evaluated the cytotoxic effect of Paclitaxel-induced MSCs on CSC viability using MTT assays. Flow cytometry analysis assessed apoptosis induction via annexin V-PI staining and Nrf2 and Caspase-3 gene expression were measure by qRT-PCR analysis. Results: MSCs exhibited typical adherence and differentiation capabilities, confirming their mesenchymal lineage. CSCs displayed an elongated morphology and expressed CD44+/CD24-, characteristic of stem-like behavior. Paclitaxel induced dose-dependent Nrf2 gene expression in MSCs. Co-culture with Paclitaxel-induced MSCs reduced CSC viability in a dose-dependent manner, with a significant decrease observed at a 5:1 MSCs:CSC ratio. Co-culture decreased the Nrf2 gene expression and increased apoptosis in CSCs, with higher caspase-3 gene expression compared to solitary paclitaxel treatment. Conclusion: Paclitaxel-induced MSCs decreased Nrf2 expression and significantly decreased CSC viability while enhancing apoptosis. This suggests a potential strategy to mitigate paclitaxel resistance in CD44+/CD24- CSCs. Leveraging Paclitaxel-induced MSCs presents a promising avenue for targeting Nrf2 and promoting apoptosis in CSCs, potentially improving the efficacy of chemotherapy and addressing resistance mechanisms in cancer treatment.


  • Open Access

    Intercontinental Comparison of Immunohistochemical Subtypes Among Individuals With Breast Cancer in South-East Asia and South America: A Scoping Systematic Review and Meta-Analysis of Observational Studies

    by Dedy Hermansyah, Naufal Nandita Firsty, Ruth Hasian Nami Siagian, Najwa Nandita Dwinda

    Intercontinental Comparison of Immunohistochemical Subtypes Among Individuals With Breast Cancer in South-East Asia and South America: A Scoping Systematic Review and Meta-Analysis of Observational Studies


  • Open Access

    Curcuma longa extract inhibits migration by reducing MMP-9 and Rac-1 expression in highly metastatic breast cancer cells

    by Dedy Hermansyah, Desiree Anggia Paramita, Adi Muradi Muhar, Nur Dina Amalina

    Background and purpose: Highly metastatic breast cancer is a population of cancer cells that has metastasized to other organs in the body leading to apoptosis resistance. It was reported that MDAMB-231 cells contain lower levels of reactive oxygen species associated with metastatic capability. Curcuma longa (CL) possesses cytotoxic effects in several cancer cells including metastatic breast cancer cells. This study aimed to investigate the effect of CL-inhibited cell migration in highly metastatic breast cancer MDAMB-231 cells. Experimental approach: CL was extracted under maceration with methanol. The cytotoxic effect on single and combination treatment of CL was assessed through the MTT assay. Migration analysis was evaluated using scratch wound healing assay, MMP-9 expression by gelatine zymography, Rac-1, and MMP-9 gene expression using Real-Time Quantitative Reverse transcription polymerase chain reaction (qRT-PCR). The apoptosis induction was analyzed through Bax gene expression and Bcl-2 protein expression. Findings/Results: We found that CL inhibits the growth of MDAMB-231 cells, induces Bax gene expression, and suppresses Bcl-2 expression in a dose-dependent manner. Moreover, cancer cell migration was suppressed by the presence of CL. qRT-PCR and gelatine zymography assay showed that CL downregulates Rac-1 and MMP-9 gene expression. Conclusion and implications: CL could inhibit the growth and migration of highly metastatic breast cancer cells by reducing the Rac-1 gene expression and regulating apoptosis protein expression.


  • Open Access

    The Relationship Between KI67 Expression and Grading with Chemotherapy Response in Triple-Negative Breast Cancer Patients at Haji Adam Malik General Hospital, Medan

    by Edy Putra, Dedy Hermansyah, Endi Pasaribu, Putri Eyanoer

    Background: The response to chemotherapy in TNBC varies greatly, highlighting the need for predictive factors to estimate the success of the therapy. Objective: The primary aim of this study is to analyze the relationship between Ki67 expression and clinicopathological features with chemotherapy response in locally advanced TNBC. Methods: This retrospective study utilized secondary data from the medical records of locally advanced TNBC patients at Haji Adam Malik General Hospital, Medan. Out of an initial sample of 50 patients, 35 met the inclusion criteria, which required a confirmed TNBC diagnosis through histopathological and immunohistochemical examination, as well as complete clinical data. Chemotherapy response was assessed based on the World Health Organization (WHO) criteria, ensuring a standardized evaluation of treatment outcomes. Results: The majority of patients were aged ≥50 years (54.5%), with a dominant tumor size of 2–5 cm (69.7%) and high histological grading (Grade 3: 60.6%). A total of 45.5% of patients exhibited high Ki67 expression (≥30%). Chemotherapy response was categorized as complete response (12.1%), partial response (45.5%), stable disease (30.3%), and progressive disease (12.1%). Statistical analysis revealed a significant relationship between Ki67 expression and chemotherapy response (p=0.02), with patients exhibiting high Ki67 expression more frequently achieving complete or partial response. Conclusion: High Ki67 expression is a critical indicator for predicting chemotherapy response in TNBC. Integrating Ki67 assessment with other clinicopathological factors is highly recommended to enhance predictive accuracy and optimize therapeutic planning for more effective treatment outcomes.